Company:  MAGENTA THERAPEUTICS, INC ... (MGTA)
Form Type:  4
Filing Date:  12/2/2019 
CIK:  0001690585 
Address:  100 TECHNOLOGY SQUARE
5TH FLOOR
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  857-201-2700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$13.50  
Change: 
-0.92 (-6.38%)  
Trade Time: 
11:55 AM EST  
Market Cap: 
$526.36M
Trade MGTA now with 

© 2019  
Description of Business
We are a clinical-stage biotechnology company developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing and cell therapy to more patients. We completed the initial public offering of our common stock in June 2018. Transplant is a well-established and often curative medical procedure, and emerging data on stem cell gene therapy, which is stem cell transplant using gene-modified stem cells, suggest the potential for meaningful benefit with this newer form of transplant. Stem cell transplant and stem cell gene therapies use the same widely-adopted decades-old transplant process. As it exists today, stem cell transplant is a large market opportunity, and improvements to the current approaches could enable better stem cell transplant and extend stem cell transplant to more patients.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES